September 2020 Issue Table Of Contents
Source: Life Science Leader

From The Editor
Feature Articles
Capitol Perspectives
CEO Corner
- Building a Biotech: The Third Key Ingredient Beyond Innovation & Funding
- Moving From Crisis To Lasting Change
Companies To Watch
From Policy to Execution
Industry Research
Inside The Industry
- Drug Pricing Reform Twists And Turns In The COVID-19 Era
- 5 Steps To Prepare For A Third-Party Drug Price Evaluation
- Public-Private Partnerships Can Lead To Long-Term Success
- Eyes On Horizon, Buying Into Bio
- How Flexion Pivoted To Become A Commercial Biotech
- What To Know About Patents For Software As A Medical Device
Leadership Lessons
Ask The Board
- What Additional Protocols Have You Observed Being Implemented To Protect Biopharma Manufacturing Employees, And What Impact Do You Anticipate On The Bottom Line From These Added Costs?
- What Are Some Of The Best Business Practices That Didn’t Exist At Your Company Prior To COVID-19 That Will Likely Continue Long After The Pandemic Subsides?
- Given The Success Of Virtual Investor Pitching, Do You Think Events Like JPM And BTS Will Remain Relevant?
This website uses cookies to ensure you get the best experience on our website. Learn more